Team

Strategic Advisors

Deborah Ancona, PhD
Seley Distinguished Professor of Management; Professor of Organization Studies; Faculty Director, MIT Leadership Center, MIT Sloan School of Management
Retsef Levi, PhD
J. Spencer Standish (1945) Professor of Management; Associate Professor of Operations Management, MIT Sloan School of Management
Denny A. Ausiello, MD
CATCH Co-Founder, Director; Jackson Professor of Clinical Medicine, Harvard Medical School; Chief of Medicine, MGH; Director, Pfizer
Andrew Lo, PhD
Charles E. and Susan T. Harris Professor of Finance; Director, Laboratory for Financial Engineering, MIT Sloan School of Management
Ernest Berndt, PhD, MS
Louis E Seley Professor of Applied Economics, Sloan School of Management; Co-director Biomedical Enterprise Program
Ram Sasisekharan, PhD
Director, Harvard – MIT Health Sciences and Technology, Edward Hood Taplin Professor of Health Sciences & Technology and Biological Engineering, MIT
Charles L. Cooney, PhD
Robert T. Haslam Professor of Chemical Engineering, MIT; Faculty Director, Deshpande Center for Technological Innovation
Phillip A. Sharp, PhD
Institute Professor, Koch Institute for Integrative Cancer Research, MIT
Michael A. Cusumano, PhD
Sloan Management Review Distinguished Professor of Management, MIT Sloan School of Management
Anthony Sinskey, ScD
Faculty Director, CBI; Professor of Biology and Health Sciences and Technology, MIT
Elazer Edelman, MD, PhD, FACC
Thomas D & Virginia W Cabot Professor of HST, Health Sciences and Technology Program, MIT

Executive Committee

The Executive Committee for NEWDIGS is an advisory body, which meets once a quarter throughout the calendar year. The role of the Executive Committee is to contribute ideas for projects, vet new opportunities, and disseminate emerging insights and recommendations from NEWDIGS activities The Executive Committee will assist with outreach to potential sponsors and endorse the goals of NEWDIGS projects as well the alignment of new projects with NEWDIGS mission and priorities; It has no financial or fiduciary responsibility, nor does it make any product-specific decisions. Typical agenda items include research updates, workshop opportunities, new mini-consortia proposals and pending publications.

Elizabeth Cobbs, PhD
Head, Medical Policy & Quality Research Merck & Co. Inc.
Kenneth A. Oye, PhD
Associate Professor of Political Science and Engineering Systems;; Co-Director, MIT Program on Emerging Technologies Massachusetts Institute of Technology
Nick Crabb, PhD
Program Director, Scientific Affairs National Institute for Health & Clinical Excellence (NICE)
Edmund J. Pezalla, MD, MPH
Scholar in Residence Duke-Robert J. Margolis Center for Health Policy at Duke University
Anne-Virginie Eggimann, MSc
Vice President, Regulatory Science bluebird bio
Peter Saltonsall
President and CEO National Organization for Rare Disorders (NORD)
Hans-Georg Eichler, MD, MSc
Senior Medical Officer European Medicines Agency
Harry Selker, MD, MSPH
Dean, Clinical and Translational Science Institute Institute for Clinical Research & Health Policy Studies Tufts University
Gigi Hirsch, M.D.
Executive Director MIT Center for Biomedical Innovation Massachusetts Institute of Technology
Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Managment Massachusetts Institute of Technologye; President, Co-Bio Consulting
Hilary M. Malone, PhD
Chief Regulatory Officer, Head of Global Regulatory Affairs Sanofi

Affiliated Faculty and Researchers

Allison Ackerman Shrier, MD
President, Riptide Management
Kenneth A. Oye, PhD
Associate Professor of Political Science and Engineering Systems;; Co-Director, MIT Program on Emerging Technologies Massachusetts Institute of Technology
Ramy Arnaout, MD, DPhil
Associate Director, Department of Pathology, Beth Israel Deaconess Medical Center
Nitin R. Patel, PhD
Research Affiliate, MIT Center for Biomedical Innovation; Founder, Chairman, and Chief Technology Officer, Cytel Statistical Software and Services
Ernest Berndt, PhD, MS
Louis E Seley Professor of Applied Economics, Sloan School of Management; Co-director Biomedical Enterprise Program
G.K. Raju, PhD
CBI Distinguished Fellow; Chairman, CBI Biomanufacturing Steering Committee; Executive Director, MIT Pharmaceutical Manufacturing Initiative
Jeff Brown, PhD
Assistant Professor, Department of Population Medicine, Harvard Medical School
J. Russell Teagarden, DMH, MA
Senior Health Care Practitioner, Independent Advisor, Researcher and Writer
Chester Drum, MD, PhD
Assistant Professor, Department of Medicine, National University of Singapore
Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Managment Massachusetts Institute of Technologye; President, Co-Bio Consulting
Judy Maro, PhD, MS
Research Affiliate, Center for Biomedical Innovation, Research Fellow in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute

Program Leadership Office

Gigi Hirsch, M.D.
ghirsch@mit.edu
Executive Director MIT Center for Biomedical Innovation Massachusetts Institute of Technology
617-253-9609
Katie Torrence
ktorrenc@mit.edu
Project Coordinator, Financing and Reimbursement of Cures in the US (FoCUS)
617-324-2695
Kay Larholt, ScD
klarholt@mit.edu
Director of Integrated Knowledge Solutions, WISDOM Program
617-253-7333
Mo Yang, PhD
Health Economics and Financing Research Lead, Financing and Reimbursement of Cures in the US (FoCUS) Program
617-324-2695
Eric A. Small
easmall@mit.edu
Administrative Coordinator, NEWDIGS
617-324-4841
Deborah L. Young, EMBA, Ed.M.
debyoung@mit.edu
Director of Operations
617-324-7756